About the Sezary Syndrome Session
Sebaceous cell carcinoma (SCC) is a rare and aggressive form of skin cancer originating in the sebaceous glands. Although it represents only a small fraction of skin malignancies, its tendency to metastasize makes it a significant health concern. Research on SCC primarily focuses on early detection methods and effective treatments to improve patient outcomes. Recent advancements in genomic analysis have shed light on the genetic mutations driving SCC development, paving the way for targeted therapies. Additionally, immunotherapies and photodynamic therapy are being explored as promising treatment modalities. Collaborative efforts among clinicians, researchers, and pharmaceutical companies aim to unravel the complexities of SCC biology and develop personalized treatment approaches for better management of this challenging disease.
Topics Covered in Sezary Syndrome
Cutaneous T-Cell Lymphoma
Erythroderma
Blood Flow Cytometry
Extracorporeal Photopheresis
Allogeneic Transplant
Pruritus Management
Related Scientific Sessions at CIOC 2027
Why Attend the Sezary Syndrome Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Sezary Syndrome work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Sezary Syndrome research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Sezary Syndrome track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Sezary Syndrome Conference 2027 — FAQs
What is the Sezary Syndrome track at CIOC 2027?
The Sezary Syndrome track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Sezary Syndrome. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Sezary Syndrome sessions?
Cancer researchers and clinicians, educators and students with an interest in Sezary Syndrome are all welcome — whether presenting or attending.
Can I present my research in the Sezary Syndrome track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Sezary Syndrome sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Sezary Syndrome track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.